Medigus Ltd Sponsored

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Medigus Ltd (NASDAQ: MDGS) subsidiary and a developer and manufacturer of customized micro visual solutions and supplementary technologies ScoutCam Inc (OTC: SCTC) appointed Yovav Sameah ScoutCam's new CEO. Sameah will replace Dr. Yaron Silberman, who will depart to pursue new opportunities.

ScoutCam Names Yovav Sameah As Chief Executive

Medigus Announces Exercise and Closing of Underwriter's Over-Allotment Option

OMER, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc (OTCQB:SCTC), Medigus' subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, appointed Mr. Yovav Sameah as ScoutCam's new Chief Executive Officer. Mr. Sameah will replace Dr. Yaron Silberman, who will step down to pursue new opportunities.

Medigus: ScoutCam Appoints Seasoned Hi-Tech Executive Yovav Sameah as Chief Executive Officer

NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $8.5 Million Follow-On Offering for Medigus Ltd. (Nasdaq: MDGS) About Medigus Ltd.

Aegis Capital Corp. Acted as Sole Bookrunner on a $8.5 Million Follow-On Offering for Medigus Ltd. (Nasdaq: MDGS)

OMER, Israel, March 01, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,258,438 American Depositary Shares (the “ADSs”). Each ADS was sold to the public at a price per ADS of $2.60. The gross proceeds to the Company from this offering are expected to be approximately $8.5 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Medigus Closes $8.5 Million Underwritten Public Offering of American Depositary Shares

OMER, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of ﻿3,258,438 American Depositary Shares (the “ADSs”). Each ADS is being sold to the public at a price per ADS of $2.60. The gross proceeds to the Company from this offering are expected to be approximately $8.5 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about March 1, 2021, subject to customary closing conditions.

Medigus Prices $8.5 Million Underwritten Public Offering of American Depositary Shares

OMER, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (the “Company”), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it intends to offer its American Depositary Shares (“ADSs”) for sale in an underwritten public offering. In addition, the Company expects to grant the underwriter an option to purchase an additional 15 percent of the ADSs offered in the public offering solely to cover over-allotments, if any, exercisable for 45 days, but not to close after March 31, 2021 unless the Company has filed its annual report on Form 20-F with the SEC before that date. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Medigus Announces Proposed Underwritten Public Offering of American Depositary Shares

Eventer signed an exclusive license agreement with Screenz and will invest $1.5 million for the adaptation of Screenz technology Eventer signed an exclusive license agreement with Screenz and will invest $1.5 million for the adaptation of Screenz technology

Medigus: Eventer Targets the Multi-billion Dollar Virtual Conference Market

The stock price of Medigus (NASDAQ: MDGS) is trading at over 10% pre-market. This is why it happened.

MDGS Stock Price Increases Over 10% Pre-Market: Why It Happened

Former designer of Italian vehicles manufacturer, Amir Zaid and leading manufacturer of high-end scooters, E-mobility and Skiing Machines, Weijian Zhou will join Medigus, via its wholly owned subsidiary Charging Robotics, in the Joint Venture

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with EMuze Founders

OMER, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc. (OTCQB: SCTC), Medigus' subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, that Mr. Mori Arkin has been appointed to its board of directors.

Medigus: Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam's Board of Directors

In 2020 the brand recorded revenues of $2.5 million with net profit of approximately 40%, according to the unaudited information provided to SmartRepair Pro In 2020 the brand recorded revenues of $2.5 million with net profit of approximately 40%, according to the unaudited information provided to SmartRepair Pro

Medigus: Smart Repair Pro Signed Agreement to Purchase Leading Fitness Toys Brand in its Category on Amazon Marketplace for $4 Million

Smart Repair Pro Intends to upgrade the brands ratings and sales by using its unique technology and know-how

Medigus: Smart Repair Pro Expands its Presence on Amazon Marketplace with Agreement to Purchase Two New Brands

NEW YORK, NY / ACCESSWIRE / January 13, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Follow-On Offering for Medigus (NASDAQ:MDGS) About Medigus Medigus and its subsidiaries are focused on medical-related devices and products and on internet and other online-related technologies. Medical related activities include miniaturized imaging equipment through Scoutcam Inc. (formerly known as Intellisense Solutions Inc.), innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease (GERD) using Medigus Ultrasonic Surgical Endostapler, or MUSE, and biological gels to protect patients against biological threats and prevent intrusion of allergens and viruses through the upper airways and eye cavities through a stake and licensing arrangement with Polyrizon Ltd.

Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Follow-On Offering for Medigus (NASDAQ: MDGS)

OMER, Israel, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq, TASE: MDGS) (“Medigus” or “the Company”), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,659,735 American Depositary Shares (the “ADSs”). Each ADS was sold to the public at a price per ADS of $2.30. The gross proceeds to the Company from this offering are expected to be approximately $8.4 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Medigus Closes $8.4 Million Underwritten Public Offering of American Depositary Shares

OMER, Israel, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq, TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of ﻿3,659,735 American Depositary Shares (the “ADSs”). Each ADS is being sold to the public at a price per ADS of $2.3. The gross proceeds to the Company from this offering are expected to be approximately $8.4 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Medigus Prices $8.4Million Underwritten Public Offering of American Depositary Shares

Shares of Israeli tech company Medigus Ltd. soared 44% in premarket trade Friday, after the company said it's struck a deal to expand its electric vehicle operations.

Israel's Medigus soars 44% premarket after saying it will buy electric vehicle IP and patent

Medigus entered an agreement to acquire IP and know-how including a provisional patent submitted in the USA for electric vehicles' wireless robotic charging pad﻿

Medigus Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Smart Repair Pro and Purex achieved together more than 214% growth in revenues in 2020 as compared to 2019

Medigus closes an investment in Smart Repair Pro and Purex, each Operating on the Amazon Marketplace

The development projects are focused on visual inspection capabilities for on the ground maintenance and in-flight monitoring of unmanned aerial vehicles The development projects are focused on visual inspection capabilities for on the ground maintenance and in-flight monitoring of unmanned aerial vehicles

Medigus: ScoutCam Announces Three Development Projects with the Israeli Air Force

OMER, Israel, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that it was informed by Smart Repair Pro, Inc. a data-driven e-commerce company operating on the Amazon Marketplace, that all of Amazon's required regulatory processes were completed, which allows for the opening of its store in Singapore. Following Amazon's approval, Smart Repair Pro is preparing to launch its brands for the first time in these two countries. Smart Repair Pro has already received Amazon's approval to launch in Australia, the United Kingdom and four leading countries in Europe and operates in the U.S. today.

Medigus: Smart Repair Pro gains Amazon's approval for launch in Singapore

OMER, Israel, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq, TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 7,098,491 American Depositary Shares (the “ADSs”). Each ADS was sold to the public at a price per ADS of $1.83. The gross proceeds to the Company from this offering are expected to be approximately $13 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Medigus Closes $13 Million Underwritten Public Offering of ADSs

OMER, Israel, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq, TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of 7,098,491 American Depositary Shares (the “ADSs”). Each ADS is being sold to the public at a price per ADS of $1.83. The gross proceeds to the Company from this offering are expected to be approximately $13 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Medigus Prices $13 Million Underwritten Public Offering of ADSs

Leading media corporations such as Fox, ABC, Disney, Univision, Viacom and Jio by Reliance Industries Limited, a Fortune 500 company have already used Screenz' technology platform

Medigus: Eventer Signs Commercial Licensing Agreement with Screenz, A Virtual Event and Entertainment Technology Company

Medigus plans to form a joint venture with EMuze founders to develop and potentially commercialize EV-based micro-mobility vehicles for urban and logistics transportation.

News for Medigus Ltd Sponsored Stock (MDGS)